Rebecca Bowen
- Cancer Research top 10%
- Breast Cancer Treatment Studies 4
- Oncology top 10%
- HER2/EGFR in Cancer Research 4
- Global Cancer Incidence and Screening 4
- Cancer Treatment and Pharmacology 4
- Genetics top 10%
- BRCA gene mutations in cancer 4
- Epidemiology top 10%
-
- Ovarian cancer diagnosis and treatment 8
-
- Advanced Breast Cancer Therapies 4
- Prostate Cancer Treatment and Research 4
- Co-authors
- J. Louise JonesAndrew HeronJames E. GrahamEtienne RaimondeauBarbara A. IsraelJeanine AlbuDavid B. AllisonRichard L. Atkinson
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- British Journal of Cancer (5 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Rebecca Bowen
38 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 284
- Oncology 387
- Genetics 270
- Epidemiology 289
- Molecular Biology 573
Countries citing papers authored by Rebecca Bowen
This map shows the geographic impact of Rebecca Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Bowen more than expected).
Fields of papers citing papers by Rebecca Bowen
This network shows the impact of papers produced by Rebecca Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Bowen. The network helps show where Rebecca Bowen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rebecca Bowen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 49 | |
| 8 | 2021 | 2 | |
| 9 | Targeted nanopore sequencing with Cas9-guided adapter ligationbreakdown → | 2020 | 266 |
| 10 | 2019 | 117 | |
| 11 | 2016 | 2 | |
| 12 | 2013 | 182 | |
| 13 | 2013 | 52 | |
| 14 | 2012 | 39 | |
| 15 | 2010 | 95 | |
| 16 | 2008 | 127 | |
| 17 | 2008 | 132 | |
| 18 | 2008 | 14 | |
| 19 | 2008 | 2 | |
| 20 | 2004 | 219 |
About Rebecca Bowen
Rebecca Bowen is a scholar working on Reproductive Medicine, Oncology and Cancer Research, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (8 papers), BRCA gene mutations in cancer (4 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers), Global Cancer Incidence and Screening (4 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (4 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Cancer Research (284 citations), Oncology (387 citations) and Genetics (270 citations). Rebecca Bowen has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include J. Louise Jones, Andrew Heron, James E. Graham, Etienne Raimondeau, Barbara A. Israel, Jeanine Albu, David B. Allison, Richard L. Atkinson, Nikhil V. Dhurandhar and Ayanna S. Augustus. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.